tiprankstipranks
Trending News
More News >

Cardiex Completes $2.4 Million Institutional Placement for Expansion

Story Highlights
Cardiex Completes $2.4 Million Institutional Placement for Expansion

Confident Investing Starts Here:

The latest update is out from CardieX ( (AU:CDX) ).

Cardiex has successfully completed an institutional placement, raising $2.4 million by issuing over 60 million fully paid ordinary shares to institutional and sophisticated investors at $0.04 per share. The funds will be used for manufacturing, marketing, sales activities, and commercial expansion related to the CONNEQT Pulse device, enhancing Cardiex’s operational capacity and market positioning.

More about CardieX

Cardiex is a company focused on advancing medical technology for vascular health, offering products such as medical and home health devices, and digital solutions targeting hypertension, cardiovascular disease, and other vascular health disorders. Their technology is based on the SphygmoCor® vascular biomarker technology, and they are listed on the Australian Stock Exchange under the ticker ASX:CDX.

Average Trading Volume: 247,420

Technical Sentiment Signal: Sell

Current Market Cap: A$17.87M

For a thorough assessment of CDX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App